RITTER PHARMACEUTICALS INC's ticker is RTTR and the CUSIP is 767836109. A total of 10 filers reported holding RITTER PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $42,000 | -40.8% | 121,729 | -3.7% | 0.00% | – |
| Q2 2017 | $71,000 | -69.4% | 126,429 | -22.6% | 0.00% | – |
| Q1 2017 | $232,000 | -31.6% | 163,361 | +30.7% | 0.00% | – |
| Q4 2016 | $339,000 | +235.6% | 124,989 | +107.9% | 0.00% | – |
| Q3 2016 | $101,000 | +9.8% | 60,130 | 0.0% | 0.00% | – |
| Q2 2016 | $92,000 | +33.3% | 60,130 | 0.0% | 0.00% | – |
| Q1 2016 | $69,000 | -32.4% | 60,130 | +0.2% | 0.00% | – |
| Q4 2015 | $102,000 | -9.7% | 60,031 | +9.1% | 0.00% | – |
| Q3 2015 | $113,000 | – | 55,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 4,657,800 | $1,630,000 | 0.11% |
| ARMISTICE CAPITAL, LLC | 1,900,000 | $665,000 | 0.08% |
| Alyeska Investment Group, L.P. | 4,462,139 | $1,562,000 | 0.01% |
| Alyeska Investment Group, L.P. | 4,250,000 | $1,488,000 | 0.01% |
| Baker Brothers Advisors | 2,800,000 | $980,000 | 0.01% |
| Paradigm Financial Advisors, LLC | 25,000 | $11,000 | 0.00% |
| Virtu Financial LLC | 45,568 | $16,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11,000 | $4,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 29,614 | $10,000 | 0.00% |
| Creative Planning | 95,600 | $33,000 | 0.00% |